Shao-Lai Zhou (Shaolai Zhou)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Venues

Journal of gastroenterology

Hepatology (Baltimore, Md.)

Cancer immunology, immunotherapy : CII

NPJ genomic medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hao-Yang Xin, Ji-Xue Zou, Rong-Qi Sun, Zhi-Qiang Hu, Zhuo Chen, Chu-Bin Luo, Zheng-Jun Zhou, Peng-Cheng Wang, Jia Li, Song-Yang Yu, Kai-Xuan Liu, Jia Fan, Jian Zhou, Shao-Lai Zhou
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma. Journal of gastroenterology (2024)
Hao-Yang Xin, Ji-Xue Zou, Rong-Qi Sun, Zhi-Qiang Hu, Zhuo Chen, Chu-Bin Luo, Zheng-Jun Zhou, Peng-Cheng Wang, Jia Li, Song-Yang Yu, Kai-Xuan Liu, Jia Fan, Jian Zhou, Shao-Lai Zhou
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma. Journal of gastroenterology 59 (5) (2024)
Hao-Yang Xin, Ji-Xue Zou, Rong-Qi Sun, Zhi-Qiang Hu, Zhuo Chen, Chu-Bin Luo, Zheng-Jun Zhou, Peng-Cheng Wang, Jia Li, Song-Yang Yu, Kai-Xuan Liu, Jia Fan, Jian Zhou, Shao-Lai Zhou
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma. Journal of gastroenterology 59 (5) (2024)
Hao-Yang Xin, Ji-Xue Zou, Rong-Qi Sun, Zhi-Qiang Hu, Zhuo Chen, Chu-Bin Luo, Zheng-Jun Zhou, Peng-Cheng Wang, Jia Li, Song-Yang Yu, Kai-Xuan Liu, Jia Fan, Jian Zhou, Shao-Lai Zhou
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma. Journal of gastroenterology 59 (5) (2024)
Hao-Yang Xin, Ji-Xue Zou, Rong-Qi Sun, Zhi-Qiang Hu, Zhuo Chen, Chu-Bin Luo, Zheng-Jun Zhou, Peng-Cheng Wang, Jia Li, Song-Yang Yu, Kai-Xuan Liu, Jia Fan, Jian Zhou, Shao-Lai Zhou
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma. Journal of gastroenterology 59 (5) (2024)
Dan Yin, Zhi-Qiang Hu, Chu-Bin Luo, Xiao-Yi Wang, Hao-Yang Xin, Rong-Qi Sun, Peng-Cheng Wang, Jia Li, Jia Fan, Zheng-Jun Zhou, Jian Zhou, Shao-Lai Zhou
LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2. Clinical and translational medicine 11 (5) (2022)
Jian Zhou, Shao-Lai Zhou, Chubin Luo
Reply. Hepatology (Baltimore, Md.) 76 (2) (2022)
Shao-Lai Zhou, Zheng-Jun Zhou, Cheng-Li Song, Hao-Yang Xin, Zhi-Qiang Hu, Chu-Bin Luo, Yi-Jie Luo, Jia Li, Zhi Dai, Xin-Rong Yang, Ying-Hong Shi, Zheng Wang, Xiao-Wu Huang, Jia Fan, Jian Zhou
Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence. Signal transduction and targeted therapy 7 (1) (2022)
Jia Li, Zhi-Qiang Hu, Song-Yang Yu, Li Mao, Zheng-Jun Zhou, Peng-Cheng Wang, Yu Gong, Sheng Su, Jian Zhou, Jia Fan, Shao-Lai Zhou, Xiao-Wu Huang
CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma. Cancer research 82 (6) (2022)
Chubin Luo, Haoyang Xin, Zhengjun Zhou, Zhiqiang Hu, Rongqi Sun, Na Yao, Qiman Sun, Uyunbilig Borjigin, Xia Wu, Jia Fan, Xiaowu Huang, Shao-Lai Zhou, Jian Zhou
Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression. Hepatology (Baltimore, Md.) 76 (4) (2022)
Shao-Lai Zhou, Chu-Bin Luo, Cheng-Li Song, Zheng-Jun Zhou, Hao-Yang Xin, Zhi-Qiang Hu, Rong-Qi Sun, Jia Fan, Jian Zhou
Genomic evolution and the impact of SLIT2 mutation in relapsed intrahepatic cholangiocarcinoma. Hepatology (Baltimore, Md.) (2021)
Peng-Cheng Wang, Zhi-Qiang Hu, Shao-Lai Zhou, Song-Yang Yu, Li Mao, Sheng Su, Jia Li, Ning Ren, Xiao-Wu Huang
The Spatial Distribution of Immune Cell Subpopulations in Hepatocellular Carcinoma. Cancer science (2021)
Zhengjun Zhou, Pengcheng Wang, Rongqi Sun, Jia Li, Zhiqiang Hu, Haoyang Xin, Chubin Luo, Jian Zhou, Jia Fan, Shao-Lai Zhou
Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3. Journal for immunotherapy of cancer 9 (3) (2021)
Zhi-Qiang Hu, Shao-Lai Zhou, Jia Li, Zheng-Jun Zhou, Peng-Cheng Wang, Hao-Yang Xin, Li Mao, Chu-Bin Luo, Song-Yang Yu, Xiao-Wu Huang, Ya Cao, Jia Fan, Jian Zhou
Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis. Hepatology (Baltimore, Md.) 72 (3) (2021)
Zhi-Qiang Hu, Hao-Yang Xin, Chu-Bin Luo, Jia Li, Zheng-Jun Zhou, Ji-Xue Zou, Shao-Lai Zhou
Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma. Cancer immunology, immunotherapy : CII 70 (2) (2020)
Zheng-Jun Zhou, Chu-Bin Luo, Hao-Yang Xin, Zhi-Qiang Hu, Gui-Qi Zhu, Jia Li, Shao-Lai Zhou
MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling. NPJ genomic medicine 5 (2020)
Zhi-Qiang Hu, Zheng-Jun Zhou, Chu-Bin Luo, Hao-Yang Xin, Jia Li, Song-Yang Yu, Shao-Lai Zhou
Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection. Cancer cell international 20 (1) (2020)
Zheng-Jun Zhou, Hao-Yang Xin, Jia Li, Zhi-Qiang Hu, Chu-Bin Luo, Shao-Lai Zhou
Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection. Cancer immunology, immunotherapy : CII 68 (8) (2019)

Shao-Lai Zhou.css-eqlu8i{font-size:small;padding-left:4px;} (Shaolai Zhou)

Publication Activity (10 Years)

Top Topics

Top Venues

Shao-Lai Zhou (Shaolai Zhou)